Investigation for Long-Term Investors in Shares Seres Therapeutics Inc (NASDAQ:MCRB) Announced
An investigation on behalf of current long-term investors in shares of Seres Therapeutics Inc (NASDAQ:MCRB) concerning potential breaches of fiduciary duties by certain directors and officers of Seres Therapeutics was announced.
View full press release